Identifying the Leukemia Stem Cell Niche Mediating Drug Resistance in Flt3-ITD Acute Myeloid Leukemia

Nick R Anderson(University of Alabama at Birmingham), Ravi Bhatia(University of Alabama at Birmingham), Shaowei Qiu(Chinese Academy of Medical Sciences & Peking Union Medical College), Mason W Harris(University of Alabama at Birmingham), Hui Li(Shanghai Stomatological Hospital), Andrew J. Paterson

Blood

November 13, 2019

10.1182/blood-2019-124379

Cited by 0

Related Papers

PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia

|Nature Genetics|2019|627

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

|Blood|2003|541

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study

|Blood|2007|536

American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care

|Journal of Clinical Oncology|2013|473

Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma

|Journal of Clinical Oncology|2017|468